BEIJING GENE+ TECHNOLOGY
Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention, early detection, as well as providing data for the implementation of precision medicine. The company claims to operate in around 100 hospitals and have served thousands of cancer patients in China.
BEIJING GENE+ TECHNOLOGY
Industry:
Health Care Life Science Medical
Founded:
2015-01-01
Address:
Changping, Beijing, China
Country:
China
Website Url:
http://www.geneplus.org.cn
Total Employee:
251+
Status:
Active
Total Funding:
181.29 M USD
Technology used in webpage:
SPF Content Delivery Network Euro Pound Sterling Japanese Yen Nginx 1.14 Nginx 1.10 HiChina DNS Nginx 1.17 Nginx 1.12
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Pathway Genomics
Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.
Redcliffe Labs
Redcliffe is a one-stop diagnostic platform offering a wide selection of tests to choose from and delivering care closer to the customer.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Employees Featured
Founder
Investors List
CCB Capital
CCB Capital investment in Series C - Beijing Gene+ Technology
Alibaba Health Information Technology
Alibaba Health Information Technology investment in Series C - Beijing Gene+ Technology
CCB International
CCB International investment in Series C - Beijing Gene+ Technology
GGV Capital
GGV Capital investment in Series C - Beijing Gene+ Technology
Harvest Capital
Harvest Capital investment in Series C - Beijing Gene+ Technology
Fortune Capital
Fortune Capital investment in Series C - Beijing Gene+ Technology
Baidu Ventures
Baidu Ventures investment in Series C - Beijing Gene+ Technology
UEC Group
UEC Group investment in Series B - Beijing Gene+ Technology
Green Pine Capital Partners
Green Pine Capital Partners investment in Series B - Beijing Gene+ Technology
Co-Stone Venture Capital
Co-Stone Venture Capital investment in Series B - Beijing Gene+ Technology
Official Site Inspections
http://www.geneplus.org.cn
- Host name: 223.71.218.89
- IP address: 223.71.218.89
- Location: Beijing China
- Latitude: 39.9288
- Longitude: 116.3889
- Timezone: Asia/Shanghai
